CBD For Multi-Modal OA Management

This lecture will review the basic pathophysiology of canine osteoarthritis as it relates to effective multi-modal management.We will discuss how the oral supplement industry is regulated and risks associated with contamination, quality assurance, safety, and efficacy. Current veterinary evidence in CBD products will be presented as well as the mechanism of action of CBD and CBDA. Various cannabinoids products currently in the market will be compared to help practitioners choose best products for osteoarthritis management.Practical advice and dosing regimens will be reviewed.